Guidelines

Primary Urethral Carcinoma

9. REFERENCES

1.Boorjian, S.A., et al. Risk factors and outcomes of urethral recurrence following radical cystectomy. Eur Urol, 2011. 60: 1266.

https://pubmed.ncbi.nlm.nih.gov/21871713/

2.Witjes, J.A., et al. EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Edn. presented at the 37th EAU Annual Congress Amsterdam, in EAU Guidelines 2022: Arnhem. The Netherlands.

https://uroweb.org/guideline/bladder-cancer-muscle-invasive-and-metastatic/

3.Gakis, G., et al. European Association of Urology Guidelines on Primary Urethral Carcinoma-2020 Update. Eur Urol Oncol, 2020. 3: 424.

https://pubmed.ncbi.nlm.nih.gov/32605889/

4.Guyatt, G.H., et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 2008. 336: 924.

https://pubmed.ncbi.nlm.nih.gov/18436948/

5.Guyatt, G.H., et al. What is “quality of evidence” and why is it important to clinicians? BMJ, 2008. 336: 995.

https://pubmed.ncbi.nlm.nih.gov/18456631/

6.Phillips, B., et al. Oxford Centre for Evidence-based Medicine Levels of Evidence. Updated by Jeremy Howick March 2009. [Access date March 2022].

https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009

7.Guyatt, G.H., et al. Going from evidence to recommendations. BMJ, 2008. 336: 1049.

https://pubmed.ncbi.nlm.nih.gov/18467413/

8.Gatta, G., et al. Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer, 2011. 47: 2493.

https://pubmed.ncbi.nlm.nih.gov/22033323/

9.Brierley, J.D., et al., TNM classification of malignant tumors. UICC International Union Against Cancer. 2017, Wiley/Blackwell. p. 208.

https://www.uicc.org/resources/tnm

10.RARECARENet. Surveillance of Rare Cancers in Europe. 2019. [Access date March 2022].

https://www.rarecancerseurope.org/rare-cancers-in-europe11.Wenzel, M., et al. Incidence rates and contemporary trends in primary urethral cancer. Cancer Causes Control, 2021. 32: 627.

https://pubmed.ncbi.nlm.nih.gov/33751293/

12.Wenzel, M., et al. Sex-Related Differences Include Stage, Histology, and Survival in Urethral Cancer Patients. Clin Genitourin Cancer, 2021. 19: 135.

https://pubmed.ncbi.nlm.nih.gov/33526327/

13.Krukowski, J., et al. Primary urethral carcinoma - unexpected cause of urethral stricture. Case report and review of the literature. Med Ultrason, 2019. 21: 494.

https://pubmed.ncbi.nlm.nih.gov/31765461/

14.Guo, H., et al. Lichen Sclerosus Accompanied by Urethral Squamous Cell Carcinoma: A Retrospective Study From a Urethral Referral Center. Am J Mens Health, 2018. 12: 1692.

https://pubmed.ncbi.nlm.nih.gov/29926751/

15.Colapinto, V., et al. Primary carcinoma of the male urethra developing after urethroplasty for stricture. J Urol, 1977. 118: 581.

https://pubmed.ncbi.nlm.nih.gov/916053/

16.Mohanty, N.K., et al. Squamous cell carcinoma of perineal urethrostomy. Urol Int, 1995. 55: 118.

https://pubmed.ncbi.nlm.nih.gov/8533195/

17.Sawczuk, I., et al. Post urethroplasty squamous cell carcinoma. N Y State J Med, 1986. 86: 261.

https://pubmed.ncbi.nlm.nih.gov/3459083/

18.Mohan, H., et al. Squamous cell carcinoma of the prostate. Int J Urol, 2003. 10: 114.

https://pubmed.ncbi.nlm.nih.gov/12588611/

19.Arva, N.C., et al. Diagnostic dilemmas of squamous differentiation in prostate carcinoma case report and review of the literature. Diagn Pathol, 2011. 6: 46.

https://pubmed.ncbi.nlm.nih.gov/21627811/

20.Cupp, M.R., et al. Detection of human papillomavirus DNA in primary squamous cell carcinoma of the male urethra. Urology, 1996. 48: 551.

https://pubmed.ncbi.nlm.nih.gov/8886059/

21.Wiener, J.S., et al. Oncogenic human papillomavirus type 16 is associated with squamous cell cancer of the male urethra. Cancer Res, 1992. 52: 5018.

https://pubmed.ncbi.nlm.nih.gov/1325290/

22.Ahmed, K., et al. Urethral diverticular carcinoma: an overview of current trends in diagnosis and management. Int Urol Nephrol, 2010. 42: 331.

https://pubmed.ncbi.nlm.nih.gov/19649767/

23.Chung, D.E., et al. Urethral diverticula in women: discrepancies between magnetic resonance imaging and surgical findings. J Urol, 2010. 183: 2265.

https://pubmed.ncbi.nlm.nih.gov/20400161/

24.Thomas, A.A., et al. Urethral diverticula in 90 female patients: a study with emphasis on neoplastic alterations. J Urol, 2008. 180: 2463.

https://pubmed.ncbi.nlm.nih.gov/18930487/

25.Libby, B., et al. Non-surgical treatment of primary female urethral cancer. Rare Tumors, 2010. 2: e55.

https://pubmed.ncbi.nlm.nih.gov/21139970/

26.Altman, D., et al. Cancer Risk After Midurethral Sling Surgery Using Polypropylene Mesh. Obstet Gynecol, 2018. 131: 469.

https://pubmed.ncbi.nlm.nih.gov/29420401/

27.Gandhi, J.S., et al. Clear cell adenocarcinoma of the male urethral tract. Indian J Pathol Microbiol, 2012. 55: 245.

https://pubmed.ncbi.nlm.nih.gov/22771656/

28.Mehra, R., et al. Primary urethral clear-cell adenocarcinoma: comprehensive analysis by surgical pathology, cytopathology, and next-generation sequencing. Am J Pathol, 2014. 184: 584.

https://pubmed.ncbi.nlm.nih.gov/24389164/

29.Visser, O., et al. Incidence and survival of rare urogenital cancers in Europe. Eur J Cancer, 2012.
48: 456.

httphttps://pubmed.ncbi.nlm.nih.gov/22119351/

30.Rabbani, F. Prognostic factors in male urethral cancer. Cancer, 2011. 117: 2426.

https://pubmed.ncbi.nlm.nih.gov/24048790/

31.Aleksic, I., et al. Primary urethral carcinoma: A Surveillance, Epidemiology, and End Results data analysis identifying predictors of cancer-specific survival. Urol Ann, 2018. 10: 170.

https://pubmed.ncbi.nlm.nih.gov/29719329/

32.Sui, W., et al. Outcomes and Prognostic Factors of Primary Urethral Cancer. Urology, 2017. 100: 180.

https://pubmed.ncbi.nlm.nih.gov/27720774/

33.Greiman, A.K., et al. Urethral diverticulum: A systematic review. Arab J Urol, 2019. 17: 49.

https://pubmed.ncbi.nlm.nih.gov/31258943/

34.WHO. Classification of Tumors. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs. Eble, J.N., Sauter, G., Epstein, J. Eds. 2004, Lyon.

https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Pathology-And-Genetics-Of-Tumours-Of-The-Urinary-System-And-Male-Genital-Organs-2004

35.Comperat, E., et al. Immunochemical and molecular assessment of urothelial neoplasms and aspects of the 2016 World Health Organization classification. Histopathology, 2016. 69: 717.

https://pubmed.ncbi.nlm.nih.gov/27353436/

36.Shanks, J.H., et al. Dataset for reporting of carcinoma of the urethra (in urethrectomy specimens): recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology, 2019. 75: 453.

https://pubmed.ncbi.nlm.nih.gov/31009090/

37.Gheiler, E.L., et al. Management of primary urethral cancer. Urology, 1998. 52: 487.

https://pubmed.ncbi.nlm.nih.gov/9730466/

38.Karnes, R.J., et al. Surgery for urethral cancer. Urol Clin North Am, 2010. 37: 445.

https://pubmed.ncbi.nlm.nih.gov/20674699/

39.Blaivas, J.G., et al. Periurethral masses: etiology and diagnosis in a large series of women. Obstet Gynecol, 2004. 103: 842.

https://pubmed.ncbi.nlm.nih.gov/15121554/

40.Barkan, G.A., et al. The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology. Acta Cytol, 2016. 60: 185.

https://pubmed.ncbi.nlm.nih.gov/27318895/

41.Touijer, A.K., et al. Role of voided urine cytology in diagnosing primary urethral carcinoma. Urology, 2004. 63: 33.

https://pubmed.ncbi.nlm.nih.gov/14751342/

42.Gakis, G., et al. Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma. Urol Int, 2016. 97: 134.

https://pubmed.ncbi.nlm.nih.gov/27462702/

43.Samm, B.J., et al. Penectomy: a technique to reduce blood loss. Urology, 1999. 53: 393.

https://pubmed.ncbi.nlm.nih.gov/9933061/

44.Donat, S.M., et al. The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer. J Urol, 2001. 165: 1580.

https://pubmed.ncbi.nlm.nih.gov/11342921/

45.Schubert, T., et al. MP11-20 The predictive accuracy between clinical staging and pathological staging in patients with primary urethral carcinoma. J Urol, 2019. 201: e135.

https://www.auajournals.org/doi/abs/10.1097/01.JU.0000555184.87550.3c

46.Del Gaizo, A., et al. Magnetic resonance imaging of solid urethral and peri-urethral lesions. Insights Imaging, 2013. 4: 461.

https://pubmed.ncbi.nlm.nih.gov/23686749/

47.Itani, M., et al. MRI of female urethra and periurethral pathologies. Int Urogynecol J, 2016. 27: 195.

https://pubmed.ncbi.nlm.nih.gov/26209954/

48.Stewart, S.B., et al. Imaging tumors of the penis and urethra. Urol Clin North Am, 2010. 37: 353.

https://pubmed.ncbi.nlm.nih.gov/20674692/

49.Kim, B., et al. Imaging of the male urethra. Semin Ultrasound CT MR, 2007. 28: 258.

https://pubmed.ncbi.nlm.nih.gov/17874650/

50.Raman, S.P., et al. Upper and Lower Tract Urothelial Imaging Using Computed Tomography Urography. Radiol Clin North Am, 2017. 55: 225.

https://pubmed.ncbi.nlm.nih.gov/28126213/

51.Gourtsoyianni, S., et al. MRI at the completion of chemoradiotherapy can accurately evaluate the extent of disease in women with advanced urethral carcinoma undergoing anterior pelvic exenteration. Clin Radiol, 2011. 66: 1072.

https://pubmed.ncbi.nlm.nih.gov/21839430/

52.Laudicella, R., et al. (18)F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma. Nucl Med Mol Imaging, 2019. 53: 296.

https://pubmed.ncbi.nlm.nih.gov/31456863/

53.Naumann, C.M., et al. Reliability of dynamic sentinel node biopsy combined with ultrasound-guided removal of sonographically suspicious lymph nodes as a diagnostic approach in patients with penile cancer with palpable inguinal lymph nodes. Urol Oncol, 2015. 33: 389.e9.

https://pubmed.ncbi.nlm.nih.gov/25934562/

54.Dayyani, F., et al. Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists. Urol Oncol, 2013. 31: 1171.

https://pubmed.ncbi.nlm.nih.gov/22534087/

55.Gakis, G., et al. Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma. World J Urol, 2016. 34: 97.

https://pubmed.ncbi.nlm.nih.gov/25981402/

56.Werntz, R.P., et al. The role of inguinal lymph node dissection in men with urethral squamous cell carcinoma. Urol Oncol, 2018. 36: 526 e1.

https://pubmed.ncbi.nlm.nih.gov/30446445/

57.Carroll, P.R., et al. Surgical anatomy of the male and female urethra. Urol Clin North Am, 1992. 19: 339.

https://pubmed.ncbi.nlm.nih.gov/1574824/

58.Sharp, D., et al., Surgery of penile and urethral carcinoma, in Campbell’s Urology, D. McDougal, A. Wein, L. Kavoussi, A. Novick, A. Partin, C. Peters & P. Ramchandani, Eds. 212, Saunders Elsevier: Philadelphia, PA, USA.

59.Abudurexiti, M., et al. Prognosis of rare pathological primary urethral carcinoma. Cancer Manag Res, 2018. 10: 6815.

https://pubmed.ncbi.nlm.nih.gov/30584373/

60.Swartz, M.A., et al. Incidence of primary urethral carcinoma in the United States. Urology, 2006.
68: 1164.

https://pubmed.ncbi.nlm.nih.gov/17141838/

61.Champ, C.E., et al. Prognostic factors and outcomes after definitive treatment of female urethral cancer: a population-based analysis. Urology, 2012. 80: 374.

https://pubmed.ncbi.nlm.nih.gov/22857759/

62.Panettieri, V., et al. External Validation of a Predictive Model of Urethral Strictures for Prostate Patients Treated With HDR Brachytherapy Boost. Front Oncol, 2020. 10: 910.

https://pubmed.ncbi.nlm.nih.gov/32596153/

63.Derksen, J.W., et al. Primary urethral carcinoma in females: an epidemiologic study on demographical factors, histological types, tumour stage and survival. World J Urol, 2013. 31: 147.

https://pubmed.ncbi.nlm.nih.gov/22614443/

64.Wenzel, M., et al. Comparison Between Urothelial and Non-Urothelial Urethral Cancer. Front Oncol, 2020. 10: 629692.

https://pubmed.ncbi.nlm.nih.gov/33585257/

65.Stone, B.V., et al. The effect of centralization of care on overall survival in primary urethral cancer. Urol Oncol, 2021. 39: 133.

https://pubmed.ncbi.nlm.nih.gov/33268273/

66.Gakis, G., et al. The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinoma. Urol Oncol, 2018. 36: 10 e7.

https://pubmed.ncbi.nlm.nih.gov/29055518/

67.Dalbagni, G., et al. Male urethral carcinoma: analysis of treatment outcome. Urology, 1999. 53: 1126.

https://pubmed.ncbi.nlm.nih.gov/10367840/

68.Smith, Y., et al. Penile-preserving surgery for male distal urethral carcinoma. BJU Int, 2007. 100: 82.

https://pubmed.ncbi.nlm.nih.gov/17488307/

69.Pedrosa, J.A., et al. Distal urethrectomy for localized penile squamous carcinoma in situ extending into the urethra: an updated series. Int Urol Nephrol, 2014. 46: 1551.

https://pubmed.ncbi.nlm.nih.gov/24633698/

70.Kulkarni, M., et al. MP10-16 Substitution urethroplasty for treatment of distal urethral carcinoma and carcinoma in situ. J. Urol 193: e117.

https://www.auajournals.org/doi/10.1016/j.juro.2015.02.417

71.Torbrand, C., et al. Diagnosing Distal Urethral Carcinomas in Men Might Be Only the Tip of the Iceberg. Clin Genitourin Cancer, 2017. 15: e1131.

https://pubmed.ncbi.nlm.nih.gov/28784424/

72.Dimarco, D.S., et al. Surgical treatment for local control of female urethral carcinoma. Urol Oncol, 2004. 22: 404.

https://pubmed.ncbi.nlm.nih.gov/15464921/

73.DiMarco, D.S., et al. Outcome of surgical treatment for primary malignant melanoma of the female urethra. J Urol, 2004. 171: 765.

https://pubmed.ncbi.nlm.nih.gov/14713806/

74.Garden, A.S., et al. Primary carcinoma of the female urethra. Results of radiation therapy. Cancer, 1993. 71: 3102.

https://pubmed.ncbi.nlm.nih.gov/8490839/

75.Milosevic, M.F., et al. Urethral carcinoma in women: results of treatment with primary radiotherapy. Radiother Oncol, 2000. 56: 29.

https://pubmed.ncbi.nlm.nih.gov/10869752/

76.Zinman, L.N., et al. Management of Proximal Primary Urethral Cancer: Should Multidisciplinary Therapy Be the Gold Standard? Urol Clin North Am, 2016. 43: 505.

https://pubmed.ncbi.nlm.nih.gov/27717436/

77.Cahn, D.B., et al. Contemporary practice patterns and survival outcomes for locally advanced urethral malignancies: A National Cancer Database Analysis. Urol Oncol, 2017. 35: 670 e15.

https://pubmed.ncbi.nlm.nih.gov/28803701/

78.Dayyani, F., et al. Management of advanced primary urethral carcinomas. BJU Int, 2014. 114: 25.

https://pubmed.ncbi.nlm.nih.gov/24447439/

79.Peyton, C.C., et al. Survival Outcomes Associated With Female Primary Urethral Carcinoma: Review of a Single Institutional Experience. Clin Genitourin Cancer, 2018. 16: e1003.

https://pubmed.ncbi.nlm.nih.gov/29859736/

80.Mano, R., et al. Primary urethral cancer: treatment patterns and associated outcomes. BJU Int, 2020. 126: 359.

https://pubmed.ncbi.nlm.nih.gov/32336001/

81.Gakis, G., et al. Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma. Ann Oncol, 2015. 26: 1754.

https://pubmed.ncbi.nlm.nih.gov/25969370/

82.Kent, M., et al. Combined chemoradiation as primary treatment for invasive male urethral cancer.
J Urol, 2015. 193: 532.

https://pubmed.ncbi.nlm.nih.gov/25088950/

83.Gakis, G. Editorial Comment to Docetaxel, cisplatin and 5-fluorouracil chemotherapy with concurrent radiation for unresectable advanced urethral carcinoma. Int J Urol, 2014. 21: 424.

https://pubmed.ncbi.nlm.nih.gov/24251884/

84.Itoh, J., et al. Docetaxel, cisplatin and 5-fluorouracil chemotherapy with concurrent radiation for unresectable advanced urethral carcinoma. Int J Urol, 2014. 21: 422.

https://pubmed.ncbi.nlm.nih.gov/24251859/

85.Hara, I., et al. Successful treatment for squamous cell carcinoma of the female urethra with combined radio- and chemotherapy. Int J Urol, 2004. 11: 678.

https://pubmed.ncbi.nlm.nih.gov/15285764/

86.Cohen, M.S., et al. Coordinated chemoradiation therapy with genital preservation for the treatment of primary invasive carcinoma of the male urethra. J Urol, 2008. 179: 536.

https://pubmed.ncbi.nlm.nih.gov/18076921/

87.Son, C.H., et al. Optimizing the Role of Surgery and Radiation Therapy in Urethral Cancer Based on Histology and Disease Extent. Int J Radiat Oncol Biol Phys, 2018. 102: 304.

https://pubmed.ncbi.nlm.nih.gov/29908944/

88.Palou Redorta, J., et al. Intravesical instillations with bacillus calmette-guerin for the treatment of carcinoma in situ involving prostatic ducts. Eur Urol, 2006. 49: 834.

https://pubmed.ncbi.nlm.nih.gov/16426729/

89.Patschan, O., et al. Systematic Review of the Role of BCG in the Treatment of Urothelial Carcinoma of the Prostatic Urethra. Bladder Cancer, 2021. 7: 213.

https://www.researchgate.net/publication/350119761

90.Njinou Ngninkeu, B., et al. Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases. J Urol, 2003. 169: 149.

https://pubmed.ncbi.nlm.nih.gov/12478124/

91.Palou, J., et al. Urothelial carcinoma of the prostate. Urology, 2007. 69: 50.

https://pubmed.ncbi.nlm.nih.gov/17280908/

92.Hillyard, R.W., Jr., et al. Superficial transitional cell carcinoma of the bladder associated with mucosal involvement of the prostatic urethra: results of treatment with intravesical bacillus Calmette-Guerin. J Urol, 1988. 139: 290.

https://pubmed.ncbi.nlm.nih.gov/3339727/

93.Solsona, E., et al. The prostate involvement as prognostic factor in patients with superficial bladder tumors. J Urol, 1995. 154: 1710.

https://pubmed.ncbi.nlm.nih.gov/7563328/

94.Vazina, A., et al. Stage specific lymph node metastasis mapping in radical cystectomy specimens.
J Urol, 2004. 171: 1830.

https://pubmed.ncbi.nlm.nih.gov/15076287/

95.Balar, A.V., et al. First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study. Lancet Oncol, 2017. 18: 1483.

https://pubmed.ncbi.nlm.nih.gov/28967485/

96.Shukla, C.J., et al. Palliation of male genital cancers. Clin Oncol (R Coll Radiol), 2010. 22: 747.

https://pubmed.ncbi.nlm.nih.gov/20800458/